InsidersTradesSigma
Orexo AB: directors' dealings · Finland · FIN-FSA
FI:orexo-abSE0000736415FI·FIN-FSAMcap 647M€Healthcare
Explore the full management transaction log of Orexo AB, a listed equity based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Orexo AB has recorded 2 insider filings. Market capitalisation: €647m. The latest transaction was filed on 2 June 2025 — Purchase. Among the most active insiders: Staffan Lindstrand. Every trade is free.
2
Insider Decl.
0
Thresholds
€8,127
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
18.42 €
Analyst consensus
1 analysts27.00 €Target 27.00 €(+47%)27.00 €
Income statement
Revenue26.0 M€
Gross profit11.5 M€44% margin
Net income639.3 M€2928.7% margin
Valuation
PER (forward)-2.6x
P/Book1.8x
Beta0.87
Balance sheet & cash
Market cap647.0 M€
Total debt491.5 M€
Free Cash Flow−195.4 M€
Debt / Equity2%
Profitability & ownership
ROE-410.9%
ROA-38.0%
% insiders18.9%
% institutions40.3%
Last declaration on 2 June 2025
Declarations2 total
Executives●Purchase16FIN-FSA
€4,9503,534 shares@ €1.40080.0008% mcap100.0% of flow
Aktie
FI:A003P189-1·
Ideal exit: 27 Feb 2026 (T+270)
Executives●Purchase31FIN-FSA
€3,1772,460 shares@ €1.29150.0005% mcap100.0% of flow
Aktie
FI:A003N442-1·
Ideal exit: 6 Jan 2026 (T+270)
2 of 2 declarations